Search Within

Michael David Offin

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (41)
  2. Meeting Abstract (40)
  3. Editorial (2)
  4. Review (1)
Groups
  1. Department of Medicine (84)
  2. GSK Faculty (84)
  3. Human Oncology and Pathogenesis Program (84)
  4. Solid Tumor Oncology Division (84)
  5. Thoracic Oncology (84)
  6. Weinberg Fellows (84)

More Groups

People
  1. Marc Ladanyi (57)
  2. Charles Rudin (45)
  3. Mark Kris (36)
  4. Alexander Drilon (34)
  5. Maria Arcila (31)
  6. Bob Li (28)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (11)
  5. 2021 (20)
  6. 2020 (9)

More Years

Publications
  1. Journal of Thoracic Oncology (17)
  2. Journal of Clinical Oncology (12)
  3. Clinical Cancer Research (10)
  4. Modern Pathology (7)
  5. JCO Precision Oncology (6)
  6. Cancer Research (4)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society of Clinical Oncology (18)
  3. American Association for Cancer Research (17)
  4. Nature Research (7)
  5. Oxford University Press (7)
  6. Nature Publishing Group (6)

More Publishers

Results (84)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive profiling of molecular dynamics in patients receiving HER2 targeted therapies by cell-free DNA analysis
    Meeting Abstract

    Gedvilaite, E.; Stewart, C.; Yang, J.; Reichel, J.; Stephens, D.; Offin, M. D.; Jing, X.; Meng, F.; You, D.; Berger, M. F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save